The Blood Grouping Reagents Market in the UK has experienced variable growth over the past decade. In 2012, the market was valued at $75.434 million, steadily increasing to $109.2 million by 2022. Notable fluctuations include a peak in 2019 at $109.71 million, followed by a modest decline in 2020 to $106.09 million. Year-on-year variations illustrate both growth spurts and contractions, with significant jumps in 2014 (18.47%) and 2019 (19.61%), contrasted by contractions in 2015 (-6.74%) and 2020 (-3.3%). The recent trend showcases moderate growth with the 2021-2022 period seeing modest increases of around 1.43 - 1.48%. The compound annual growth rate (CAGR) over the last five years stood at 3.22% (2017-2022).
Future trends to watch for include innovations in diagnostic technologies, potential regulatory changes post-Brexit, and evolving healthcare policies. Additionally, advances in personalized medicine and increased emphasis on precision healthcare may drive future market dynamics. Monitoring these factors will be critical in anticipating market shifts and opportunities.
How does the United Kingdom rank in Blood Grouping Reagents Market Size Value?
| # | 16 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 352,470,000 | 2023 | +3.9% | +3.83% | View data |
| 2 | 2 United Kingdom | 110,710,000 | 2023 | +1.38% | +3.83% | |
| 3 | 3 Spain | 103,550,000 | 2023 | +3.37% | +4.68% | View data |
| 4 | 4 Italy | 95,043,000 | 2023 | +1.51% | +1.53% | View data |
| 5 | 5 Brazil | 35,183,000 | 2023 | -3.18% | -3.78% | View data |
